Afaaf Liberty to HIV Protease Inhibitors
This is a "connection" page, showing publications Afaaf Liberty has written about HIV Protease Inhibitors.
Connection Strength
0,194
-
Biomarkers of Aging in HIV-Infected Children on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2018 08 15; 78(5):549-556.
Score: 0,148
-
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children. N Engl J Med. 2021 12 30; 385(27):2531-2543.
Score: 0,047